Source: Eur Respir J 2010; 36: 893-900
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Saggar R., Khanna D., Furst D.E., Belperio J.A., Park G.S., Weigt S.S., Kubak B., Ardehali A., Derhovanessian A., Clements P.J., Shapiro S., Hunter C., Gregson A., Fishbein M.C., Lynch III J.P., Ross D.J., Saggar R.. Systemic sclerosis and bilateral lung transplantation: a single centre experience. Eur Respir J 2010; 36: 893-900

Member's Comments

No comment yet.

Related content which might interest you: Treating systemic sclerosis with lung involvement: from observation to stem cell transplantation Source: International Congress 2018 – Respiratory medicine meets rheumatology Year: 2018 Lung transplantation in systemic sclerosis: Experience in a spanish center Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Interstitial lung disease in systemic sclerosis: where do we stand? Source: Eur Respir Rev 2015; 24: 411-419 Year: 2015 Pediatric lung transplantation: a single center experience Source: Eur Respir J 2006; 28: Suppl. 50, 780s Year: 2006 Lung transplantation (LTx) for fibrotic diseases: a single centre experience Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 The natural course of systemic sclerosis patients with interstitial lung involvement Source: Eur Respir J 2005; 26: Suppl. 49, 336s Year: 2005 Bilateral lung transplantation for pulmonary amyloidosis Source: Eur Respir J 2001; 18: Suppl. 33, 296s Year: 2001 Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease Source: Eur Respir Rev, 27 (148) 170102; 10.1183/16000617.0102-2017 Year: 2018 Clinical feature of systemic sclerosis associated with pulmonary hypertension: results of one center study Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Anti-a-enolase antibodies in systemic sclerosis identify a subset of patients with diffuse cutaneous sclerosis and interstitial lung disease Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Pulmonary function in progressive systemic sclerosis Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002 Pulmonary involvement in systemic sclerosis Source: Eur Respir Monogr 2019; 86: 90-105 Year: 2019 Longitudinal functional evaluation of interstitial lung disease in systemic sclerosis Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Lung transplantation for lymphangioleiomyomatosis: a Brazilian centre experience. Source: International Congress 2017 – Rare diseases Year: 2017 Disease course and outcome of progressive interstitial lung disease in systemic sclerosis Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new? Year: 2019 Clinical characteristics of interstitial lung fibrosis in progressive systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 95s Year: 2006 Severe lung involvement in systemic scleromyxoedema: a highly unusual finding Source: Eur Respir J 2002; 19: 976-979 Year: 2002 Pulmonary function tests for lymphangioleiomyomatosis screening in women with tuberous sclerosis complex Source: International Congress 2016 – Orphan diseases I Year: 2016 Lung transplantation for systemic sclerosis and other connective tissue diseases Source: International Congress 2017 – Difficult indications for lung transplantation Year: 2017 Idiopathic pulmonaryfibrosis: the native lung after single lung transplantation Source: Eur Respir J 2003; 22: Suppl. 45, 328s Year: 2003